Oklahoma Heart Institute

Behind every safe, high-quality patient experience is a team working to reduce risk and strengthen care. During Healthcare Risk Management Week, we thank the professionals dedicated to patient safety, compliance and continuous improvement across healthcare.

This week, we recognize the nursing assistants who bring compassion, comfort and support to patients every day. Thank you for the care you provide, the connections you build and the difference you make across our communities.

Dr. Nagasawa specializes in cardiovascular and thoracic (CVT) surgery. His professional areas of interest include robotic thoracic lung surgery, single anesthetic pulmonary procedures (i.e. diagnosis of cancer and curative resection under one anesthesia) and minimally invasive cardiac surgery.

Dr. Nagasawa’s inspiration to pursue a career as a doctor formed during the mid-1990s while watching the popular TV series, “Chicago Hope.” The TV drama outlined the working dynamics of patients, medical administrators and doctors in and outside of the hospital.

While watching the show, Dr. Nagasawa grew to admire the role that Mandy Patinkin played as a cardiothoracic surgeon. He said, “I was fascinated by the ‘heart surgery’ on the show and felt that was something I could do,” said Dr. Nagasawa.

And that is just what he did.

Since 2013, Dr. Nagasawa has been working as a heart surgeon, bringing to life the inspiration he had pictured for his career.

As Dr. Nagasawa continues his passion, he builds relationships and new connections with patients. He does so on a foundation built on trust, listening to concerns and explaining diagnosis and treatment options in an understandable manner. He reassures patients and wants them to know: “We will take good care of you.”

Elective and emergency surgery options include:
✅ Aortic aneurysm
✅ Arrhythmias
✅ Congenital heart diseases
✅ Coronary artery disease
✅ Esophageal cancers
✅ Heart failure
✅ Heart valve disease
✅ Hypertrophic cardiomyopathy
✅ Lung cancer
✅ Pericarditis
✅ Tracheal diseases

Learn more at the link below ⬇️

💓 80-85% reduction rate in heart failure readmissions. That's what our CardioMEMs program has been doing since 2017.

This week, because of our excellent performance and rapid growth, Oklahoma Heart Institute (OHI) was chosen for an early release of the new HERO monitoring system (the only center in Oklahoma to participate).

What is the HERO monitoring system? It's designed to improve how patients take and send daily pulmonary artery pressure readings to their clinicians to monitor for signs of worsening heart failure.

If you or your loved ones need enhanced cardiology care, talk with your primary care physician or cardiologist to see your options.

Our hospital is committed to creating a safe environment for both our staff and patients. On this Friday, we celebrate what we’ve accomplished and look forward to the next step toward making our hospital as safe as possible.

Your health matters. Men’s Health Month is a reminder to prioritize preventive care, schedule routine checkups and pay attention to the signs your body may be giving you. Taking care of your health today can make a difference for you and your family's future.

This Pride Month, we celebrate the strength, diversity and resilience of the LGBTQ+ community. Everyone deserves compassionate, respectful care and a place where they feel seen, heard and supported. Happy Pride Month from all of us.

Today, we're remembering and honoring those who gave their lives in service to our country. 🇺🇸

Oklahoma Heart Institute (OHI) just became the first facility in the country to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II research trial.

The SUPPORT II research trial studies the Supira pVAD device’s efficiency, helping the left ventricle pump blood through the heart during high-risk stenting while treating blockages in the heart. The investigational device utilizes a smaller profile than currently available VADs and more support for the patient’s heart, potentially expanding the available treatment population and improving effectiveness and safety. OHI is the only institute in the region participating in this trial.

Congratulations to our team, led by Dr. Kamran Muhammad and Dr. Robert Smith, on this milestone success.

First on the scene, ready for anything. During EMS Week, we recognize the dedication and expertise of EMS professionals who provide critical care when every second counts.